Literature DB >> 31365766

A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.

Tatsuaki Watanabe1, Tereza Martinu1, Andrzej Chruscinski2, Kristen Boonstra1, Betty Joe1, Miho Horie3, Zehong Guan1, Ke Fan Bei1, David M Hwang4, Mingyao Liu1, Shaf Keshavjee1, Stephen C Juvet1.   

Abstract

Chronic lung allograft dysfunction (CLAD) limits long-term survival after lung transplant (LT). Ischemia-reperfusion injury (IRI) promotes chronic rejection (CR) and CLAD, but the underlying mechanisms are not well understood. To examine mechanisms linking IRI to CR, a mouse orthotopic LT model using a minor alloantigen strain mismatch (C57BL/10 [B10, H-2b ] → C57BL/6 [B6, H-2b ]) and isograft controls (B6→B6) was used with antecedent minimal or prolonged graft storage. The latter resulted in IRI with subsequent airway and parenchymal fibrosis in prolonged storage allografts but not isografts. This pattern of CR after IRI was associated with the formation of B cell-rich tertiary lymphoid organs within the grafts and circulating autoantibodies. These processes were attenuated by B cell depletion, despite preservation of allograft T cell content. Our observations suggest that IRI may promote B cell recruitment that drives CR after LT. These observations have implications for the mechanisms leading to CLAD after LT.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  B cell biology; animal models: murine; basic (laboratory) research/science; bronchiolitis obliterans (BOS); immunobiology; immunosuppression/immune modulation; innate immunity; lung (allograft) function/dysfunction; lung transplantation/pulmonology

Year:  2019        PMID: 31365766     DOI: 10.1111/ajt.15550

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

1.  Ferret Lung Transplantation Models Differential Lymphoid Aggregate Morphology Between Restrictive and Obstructive Forms of Chronic Lung Allograft Dysfunction.

Authors:  Thomas J Lynch; Bethany A Ahlers; Anthony M Swatek; Vitaly Ievlev; Albert C Pai; Leonard Brooks; Yinghua Tang; Idil A Evans; David K Meyerholz; John F Engelhardt; Kalpaj R Parekh
Journal:  Transplantation       Date:  2022-04-15       Impact factor: 5.385

2.  DNase to the Rescue! Clearing Mitochondrial DNA May Have NET Benefits in Lung Transplantation.

Authors:  Stephen Juvet; Tereza Martinu
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

3.  Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation.

Authors:  Terrance J Y Ku; Rafaela V P Ribeiro; Victor H Ferreira; Marcos Galasso; Shaf Keshavjee; Deepali Kumar; Marcelo Cypel; Atul Humar
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

4.  Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A.

Authors:  Ran Luo; Yichun Cheng; Dan Chang; Tingting Liu; Liu Liu; Guangchang Pei; Nanhui Zhang; Zufeng Wang; Kanglin Guo; Wei Chen; Ming Li; Li Fan; Chunxiu Zhang; Yueqiang Li; Wei Dai; Meiying Zuo; Yulin Xu; Ying Yao; Shuwang Ge; Gang Xu
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

5.  The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.

Authors:  Yifan Pang; Ananth V Charya; Michael B Keller; Arlene Sirajuddin; Yi-Ping Fu; Noa G Holtzman; Steven Z Pavletic; Sean Agbor-Enoh
Journal:  Blood Adv       Date:  2022-07-26

Review 6.  Lymphocytic Airway Inflammation in Lung Allografts.

Authors:  Jesse Santos; Daniel R Calabrese; John R Greenland
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

7.  Chronic lung allograft pathology lesions in two rat strain combinations.

Authors:  Federica Pezzuto; Francesca Lunardi; Marta Vadori; Davide Zampieri; Federica Casiraghi; Nadia Azzollini; Stefania Edith Vuljan; Marco Mammana; Luca Vedovelli; Marco Schiavon; Dario Gregori; Emanuele Cozzi; Federico Rea; Fiorella Calabrese
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

8.  Netrin-1 reduces lung ischemia-reperfusion injury by increasing the proportion of regulatory T cells.

Authors:  Zhili Chen; Yuxi Chen; Jue Zhou; Yong Li; Changyao Gong; Xiaobo Wang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 9.  The role of innate immunity in the long-term outcome of lung transplantation.

Authors:  Mitsuaki Kawashima; Stephen C Juvet
Journal:  Ann Transl Med       Date:  2020-03

Review 10.  B Cell Immunity in Lung Transplant Rejection - Effector Mechanisms and Therapeutic Implications.

Authors:  Birte Ohm; Wolfgang Jungraithmayr
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.